Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein
about
sameAs
Genome-wide and functional annotation of human E3 ubiquitin ligases identifies MULAN, a mitochondrial E3 that regulates the organelle's dynamics and signalingBRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1)The SWI/SNF protein BAF60b is ubiquitinated through a signalling process involving Rac GTPase and the RING finger protein UnkemptBRCA1/BARD1 inhibition of mRNA 3' processing involves targeted degradation of RNA polymerase II.The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic functionThe BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an unconventional linkage involving lysine residue K6 of ubiquitinCCDC98 targets BRCA1 to DNA damage sitesStructure of a Bmi-1-Ring1B polycomb group ubiquitin ligase complexDegradation of transcription repressor ZBRK1 through the ubiquitin-proteasome pathway relieves repression of Gadd45a upon DNA damageBinding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complexTargeting New Candidate Genes by Small Molecules Approaching Neurodegenerative DiseasesRINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesisThe yeast Slx5-Slx8 DNA integrity complex displays ubiquitin ligase activity.Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligaseTumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155BRCA1 targets G2/M cell cycle proteins for ubiquitination and proteasomal degradationBARD1 participates with BRCA1 in homology-directed repair of chromosome breaksMDM2 and MDMX: Alone and together in regulation of p53Substitution of aspartic acid with glutamic acid at position 67 of the BRCA1 RING domain retains ubiquitin ligase activity and zinc(II) binding with a reduced transition temperature.Assessment of human Nter and Cter BRCA1 mutations using growth and localization assays in yeast.Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility.Rapid recruitment of BRCA1 to DNA double-strand breaks is dependent on its association with Ku80The ubiquitin system, disease, and drug discovery.USP28 is recruited to sites of DNA damage by the tandem BRCT domains of 53BP1 but plays a minor role in double-strand break metabolism.The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidyIdentification of Saccharomyces cerevisiae spindle pole body remodeling factorsDNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer.Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding.Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitinationDetermination of cell survival by RING-mediated regulation of inhibitor of apoptosis (IAP) protein abundanceZinc and human health: an update.DNA double-strand break signaling and human disorders.Connection between Tumor Suppressor BRCA1 and PTEN in Damaged DNA RepairBRCA1, PARP, and 53BP1: conditional synthetic lethality and synthetic viability.BRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIPCharacterization of an Italian founder mutation in the RING-finger domain of BRCA1.The BRCA1 variant p.Ser36Tyr abrogates BRCA1 protein function and potentially confers a moderate risk of breast cancer.MID1 catalyzes the ubiquitination of protein phosphatase 2A and mutations within its Bbox1 domain disrupt polyubiquitination of alpha4 but not of PP2Ac.In Vitro Enhanced Sensitivity to Cisplatin in D67Y BRCA1 RING Domain Protein.Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer
P2860
Q21144354-16338C4B-3E50-4240-A261-4B9D8DF50910Q24298165-0D775338-CA89-4B9E-9251-D182959CFEB2Q24299062-181D2EFB-86EF-4DD2-9090-055FE24A2373Q24302667-53A218AF-D09E-4F70-90A7-C1DD968C527BQ24305086-7DA8CBE7-EDAF-4BAA-B6C6-EC01C876325DQ24312959-6DF64746-C94C-4A80-B1A6-B2AE7D981444Q24321418-430BD37F-AC30-4F3E-98C2-471835334795Q24337578-9FDE0D23-53C6-4FE1-8BE8-F9E4E87686EFQ24653338-8608D05C-4193-4A9F-8A3E-04B15D9AA207Q24675257-EC93F25E-199B-4CB5-B3BD-96AF67B8C3E1Q26771812-DF85D746-EB0C-4313-A5AC-F4B4E0FA9654Q26853207-3983FB28-1B57-4222-ADA6-EF95BF5D395BQ27940090-2FF0A2FA-2BC6-4441-9E05-5810739F46B0Q28187365-C207875D-0C3A-4B49-9CE2-91C7473AEE9EQ28249114-7AA173CD-67D9-4E89-A695-DE0219F7FE40Q28389685-0FD6BCD9-9B2B-45FB-955E-221781CCC930Q28609933-EB1AEFF8-A844-4C0E-AC15-52D5576692BDQ28611422-D12B988D-C8F8-4CF4-9A1A-F342478B745CQ30395158-77DD682F-0AD3-4D60-8345-F4F9B8AD0F12Q30407141-59D4039F-79D3-412A-88EC-3E5549F5CEF1Q33231274-7FC39231-77D4-4C35-B208-A2CAEFA4C2FEQ33378036-CAF0DD88-02BB-4036-8B7B-EA555A78A358Q33384295-CEAB6BFC-F2EC-4A6B-8010-77B1DB3A5BE6Q33602611-AB1F510E-96D8-4B49-BA7A-3C6527D0E3C5Q33637754-4A4F927A-44B0-4CAA-A8E8-8240B12CA621Q33754397-3EB34698-3798-4FA7-9269-A96B5A4F0BACQ33815545-F7C7A043-FEAF-44FB-89EC-9BF1BCDB0520Q33885155-AAC1B439-795C-49B0-AF55-8F9BC0F4E465Q34097098-409BD84D-6A00-422F-B49F-BFE2C19C4F4EQ34132152-90E90B81-0BE5-444F-BA4D-CA95B8F3E657Q34231267-41521C0B-5C66-4ECC-B957-F672C145C0E1Q34360500-0F28E5F6-854E-4B01-ABE6-582E3EC117C5Q34481443-49B133FC-CD0C-442D-A928-1DDCF0417AA4Q34539782-22C398CF-89D3-4744-BC8C-62950F197853Q34863348-7F827A2F-2675-4F9C-90EF-078BEB351C66Q35091400-D617AB33-1EC4-41A1-B6EF-9D78602A4CC4Q35138569-DDA5005A-4002-4FF3-9E46-7BFC4E3EF0AEQ35245786-C0178BB3-7047-4A97-8C10-0A497E81E2ACQ35440379-1D1CE26E-F258-46E5-B3F4-E989FE63E1E6Q35448920-8494D44E-5AD7-44F7-98DC-BBD195E04CAC
P2860
Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Enhancement of BRCA1 E3 ubiqui ...... raction with the BARD1 protein
@ast
Enhancement of BRCA1 E3 ubiqui ...... raction with the BARD1 protein
@en
Enhancement of BRCA1 E3 ubiqui ...... raction with the BARD1 protein
@nl
type
label
Enhancement of BRCA1 E3 ubiqui ...... raction with the BARD1 protein
@ast
Enhancement of BRCA1 E3 ubiqui ...... raction with the BARD1 protein
@en
Enhancement of BRCA1 E3 ubiqui ...... raction with the BARD1 protein
@nl
prefLabel
Enhancement of BRCA1 E3 ubiqui ...... raction with the BARD1 protein
@ast
Enhancement of BRCA1 E3 ubiqui ...... raction with the BARD1 protein
@en
Enhancement of BRCA1 E3 ubiqui ...... raction with the BARD1 protein
@nl
P2093
P2860
P356
P1476
Enhancement of BRCA1 E3 ubiqui ...... raction with the BARD1 protein
@en
P2093
Gerald M Pao
Hong-Wu Chen
Inder M Verma
Tony Hunter
P2860
P304
P356
10.1074/JBC.M204591200
P407
P577
2003-02-14T00:00:00Z